Germany
Japan
United Kingdom
China
Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Antibodies
View as table DownloadAnti-VEGFR2 / KDR / CD309 Reference Antibody (olinvacimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Anti-VEGFR2 / KDR / CD309 Reference Antibody (vulinacimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-VEGFR2 / KDR / CD309 Reference Antibody (AT001)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-VEGFR2 / KDR / CD309 Reference Antibody (alacizumAb)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-VEGFR2 / KDR / CD309 Reference Antibody (Imclone 6.64)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Category
- Antibodies
Target Symbol
- VEGFR2 / KDR / CD309
Reactivities
- Human
Applications
- FN